Sunisam 25 mg Sunitinib Price USA | Ernest Impex Indian Exporter

Sunisam 25mg Capsule: Advanced Tyrosine Kinase Inhibition for Specialized Cancer Care

Are you searching for a reliable Sunisam 25 mg capsule exporter from India? Ernest Impex, a core division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of targeted oncology therapies. We facilitate a high-integrity, cold-chain-compliant supply chain serving Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica), ensuring that critical multi-kinase inhibitors reach medical institutions with clinical precision.

Detailed Product Overview: What is Sunisam 25mg?

Sunisam 25 mg Capsule contains Sunitinib, a potent, oral, multi-targeted tyrosine kinase inhibitor (TKI). Manufactured by Samarth Life Sciences, Sunisam is a high-quality pharmaceutical used to disrupt the signaling pathways that allow cancer cells to grow, multiply, and develop a blood supply.

For international B2B procurement, Sunisam 25mg is a vital component in treating advanced solid tumors that have become resistant to standard first-line therapies.

Primary Therapeutic Indications

Sunisam 25 mg is clinically utilized across the globe for the following:

1. Gastrointestinal Stromal Tumor (GIST): For patients whose disease has progressed or who are intolerant to Imatinib Mesylate.

2. Advanced Renal Cell Carcinoma (RCC): Used as a primary treatment for metastatic kidney cancer.

3. Pancreatic Neuroendocrine Tumors (pNET): For progressive, well-differentiated tumors in patients with unresectable locally advanced or metastatic disease.

Mechanism of Action: Multi-Targeted Pathway Inhibition

Sunisam works through a sophisticated pharmacological process known as Multi-Kinase Inhibition:

• Receptor Blockade: Sunitinib inhibits multiple receptor tyrosine kinases (RTKs), including all receptors for platelet-derived growth factors (PDGFRs) and vascular endothelial growth factors (VEGFRs).

• Anti-Angiogenesis: By blocking VEGFR, Sunisam prevents the tumor from forming new blood vessels, essentially "starving" the tumor of the nutrients required for expansion.

• Tumor Cell Proliferation: It also targets the KIT (stem cell factor receptor) and FLT3, which are critical in the growth of gastrointestinal and hematological malignancies.

• Double Action: This dual action of attacking both the tumor cells and the tumor blood supply makes it an exceptionally effective targeted therapy.

Administration and Clinical Safety

• Dosage: Sunisam is typically taken orally, once daily. For GIST and RCC, it is often administered on a schedule of 4 weeks on treatment followed by 2 weeks off.

• Storage: Store at room temperature (20°C to 25°C). Ensure the bottle is tightly closed to protect from moisture.

• Key Monitoring:

• Hepatotoxicity: Liver function tests (ALT, AST, Bilirubin) should be monitored regularly.

• Hypertension: Blood pressure should be checked at every clinical visit.

• Left Ventricular Dysfunction: Cardiac monitoring (LVEF) is recommended for patients at risk.

• Thyroid Function: Monitoring for hypothyroidism is standard clinical practice.

Why Source Sunisam from Ernest Impex?

• Authentic Indian Exporter: Direct access to genuine Samarth Life Sciences inventory, ensuring 100% product authenticity and competitive wholesale pricing for global markets.

• Global Logistics Hub: We specialize in the complex documentation and logistics required for shipping oncology meds to Washington, London, Bangkok, Canberra, Singapore, and Kingston.

• Regulatory Compliance: We provide all essential B2B documentation, including GMP compliance, batch-specific COAs, and necessary international export permits.

• Bulk Supply Stability: We specialize in large-scale fulfillment for hospital networks, oncology centers, and regional pharmaceutical distributors.